CI Investments Inc
PCVX icon

CI Investments Inc’s Vaxcyte PCVX Stock Holding History

CI Investments Inc’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,397
Closed -$50K – 1086
2025
Q3 		$50K Sell
1,397
-718
-34% -$23.8K ﹤0.01% 1024
2025
Q2 		$69K Buy
2,115
+159
+8% +$5.21K ﹤0.01% 978
2025
Q1 		$74K Sell
1,956
-1,111
-36% -$88.8K ﹤0.01% 990
2024
Q4 		$251K Buy
3,067
+607
+25% +$60.3K ﹤0.01% 669
2024
Q3 		$281K Buy
2,460
+2,263
+1,149% +$204K ﹤0.01% 586
2024
Q2 		$15K Sell
197
-2,857
-94% -$194K ﹤0.01% 1107
2024
Q1 		$209K Buy
+3,054
New +$211K ﹤0.01% 686

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

CI Investments Inc's PCVX Position: Q4 2025 in Review

CI Investments Inc sold out of Vaxcyte (PCVX) in Q4 2025, closing a stake of 1,397 shares — an estimated $50K sold.

CI Investments Inc first reported a position in PCVX in Q1 2024 and held it in 7 quarters. The position peaked at $281K in Q3 2024. 295 funds tracked by Wall St. Rank hold PCVX as of Q4 2025.

  • CI Investments Inc reported no remaining Vaxcyte position as of Q4 2025 after selling out during the quarter.
  • CI Investments Inc sold 1,397 Vaxcyte shares in Q4 2025, an estimated $50K.
  • CI Investments Inc first reported a position in Vaxcyte in Q1 2024 and held it in 7 quarters.
  • CI Investments Inc's Vaxcyte position peaked at $281K in Q3 2024.
  • 295 funds tracked by Wall St. Rank held Vaxcyte as of Q4 2025.

Based on CI Investments Inc's 13F filing for Q4 2025, filed 12 Feb 2026.